Provectus Biopharmaceuticals (PVCT) Receivables - Other (2014 - 2025)
Provectus Biopharmaceuticals (PVCT) recorded Receivables - Other of $1,291 in Q4 2025, down 99.5% from $239,726 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Receivables - Other (2014 - 2025) Analysis & Trends
Starting with Q4 2014, Provectus Biopharmaceuticals' Receivables - Other history includes 42 quarters.
- Annual Receivables - Other has declined for four straight years, with a five-year compound annual growth rate of -20.0% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $239,726 in FY2024 (-69.1%), $776,799 in FY2023 (-34.3%), $1.18 million in FY2022 (-58.6%) and $2.86 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Receivables - Other in data going back to Q4 2014.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 43.2% in Q2 2021, against a decline of 99.5% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,291.00 |
| Jun 30, 2025 | 166,471.00 |
| Mar 31, 2025 | 219,454.00 |
| Dec 31, 2024 | 239,726.00 |
| Sep 30, 2024 | 364,189.00 |
| Jun 30, 2024 | 339,283.00 |
| Mar 31, 2024 | 512,752.00 |
| Dec 31, 2023 | 776,799.00 |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 2.86 Mn |
| Sep 30, 2021 | 1,354.00 |
| Jun 30, 2021 | 5,408.00 |
| Mar 31, 2021 | 4,388.00 |
| Dec 31, 2020 | 3,930.00 |
API Access
Provectus Biopharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();